HIV / AIDS in the News

Virginia funds more than $6 million to support HIV care, other services - WAVY.com

 

Biotherapeutic metabolite repairs gut damage caused by HIV infection - News-Medical

 

U.S. says ‘error’ mislabelled every African country on AIDS conference map - National - Global News

 

Gilead Targets Black Women With HIV Prevention Campaign 08/03/2026 - MediaPost

 

AIDS 2026: Long-Acting Weekly Oral HIV Therapy Advances Toward Regulatory Review - Infection Control Today

 

Wyden, Merkley, Colleagues Demand Trump Administration Reinstate Vital HIV/AIDS Prevention Program - Merkley (.gov)

 

“Governments make decisions about lives like mine” - magazin.hiv

 

Once-Weekly Drug Combo for Controlled HIV Matches Standard Daily Regimens - MedPage Today

 

A new HIV diagnosis doesn't have to be nerve-wracking. Advocates share their advice - Advocate.com

 

Science, Systems, and Communities: Turning Progress into Impact - avac.org

 

Promise of monthly oral pill sparks renewed interest in post-exposure prophylaxis (PEP) - Aidsmap

 

Once-weekly islatravir / lenacapavir combination pill maintains HIV viral suppression - Aidsmap

 

Islatravir plus ulonivirine shows promise for weekly oral HIV treatment - Aidsmap

 

Pocan, Frankel, Randall, & Takano Lead 113 House Members in Letter to Omb Calling for Renewal of Community HIV Funds - Urban Milwaukee

 

International study shows once-weekly HIV pill performs as well as daily treatment - Medical Xpress

 

[AIDS 2026] WHO: Integration, innovation and community leadership key to ending HIV, hepatitis and STIs - European AIDS Treatment Group

 

Protecting Californians from HIV - UC Berkeley School of Public Health

 

AIDS 2026: Engineering adaptive NK cells against HIV - BioWorld News

 

Why Karnataka Is Holding HIV Camps In Colleges After 7,000+ Young People Tested Positive - Brut

 

Virginia funds more than $6 million to support HIV care, other services - WAVY.com

 

HIV prevention efforts continues despite latest funding barriers - Managed Healthcare Executive

 

Weekly Islatravir/Lenacapavir Combo Pill Maintains Viral Suppression - POZ

 

ViiV’s two-monthly HIV jab bests daily oral drugs in African teenagers - Yahoo

 

Islatravir Plus Ulonivirine Shows Promise as Weekly Oral Regimen - POZ

 

ViiV’s two-monthly HIV jab bests daily oral drugs in African teenagers - Clinical Trials Arena

 

Dolutegravir knocks down HIV faster than bictegravir - Aidsmap

 

Are 7,000 Karnataka students HIV-positive? Here's the truth - India Today

 

HIV & Medicaid; Waiting & waiting; Hail? Yes - 97.5 Glory FM

 

Thursday Shorts: HIV funding cuts, GLP-1s and absences, vaccine uncertainty, and vaccine legislation - Substack

 

Long-acting injectable treatment superior to daily pills for adolescents in African trial - Aidsmap